Cargando…
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
Several types of thalassemia (including β(0)39-thalassemia) are caused by nonsense mutations in genes controlling globin production, leading to premature translation termination and mRNA destabilization mediated by the nonsense mediated mRNA decay. Drugs (for instance, aminoglycosides) can be design...
Autores principales: | Borgatti, Monica, Altamura, Emiliano, Salvatori, Francesca, D’Aversa, Elisabetta, Altamura, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073686/ https://www.ncbi.nlm.nih.gov/pubmed/31972957 http://dx.doi.org/10.3390/jcm9020289 |
Ejemplares similares
-
UPF1 silenced cellular model systems for screening of read-through agents active on β(0)39 thalassemia point mutation
por: Salvatori, Francesca, et al.
Publicado: (2018) -
Nonaminoglycoside compounds induce readthrough of nonsense mutations
por: Du, Liutao, et al.
Publicado: (2009) -
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
por: Lombardi, Silvia, et al.
Publicado: (2020) -
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays
por: Breveglieri, Giulia, et al.
Publicado: (2017) -
Variable readthrough responsiveness of nonsense mutations in hemophilia A
por: Martorell, Lluis, et al.
Publicado: (2020)